Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach

References

• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011a. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Deliv. 8:213–224.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011b. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm. 37:583–596.
   PubMed Web of Science ®Google Scholar
• Ahad A, Raish M, Al-Mohizea AM, Al-Jenoobi FI, Alam MA. 2014. Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel. Int J Biol Macromol. 67:99–104.
   PubMed Web of Science ®Google Scholar
• Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS. 2007. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm. 341:215–220.
   PubMed Web of Science ®Google Scholar
• Babu RJ, Kanikkannan N, Kikwai L, Ortega C, Andega S, Ball K, Yim S, Singh M. 2003. The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide. J Control Release. 86:49–57.
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Singh HP, Patra CN, Rao ME. 2012. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech. 13:1416–1427.
   PubMed Web of Science ®Google Scholar
• Bessone F. 2010. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol. 16:5651–5661.
   PubMed Web of Science ®Google Scholar
• Dash RN, Mohammed H, Humaira T, Ramesh D. 2015. Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution. Saudi Pharm J. 23:528–540.
   PubMed Web of Science ®Google Scholar
• Desai P, Patlolla RR, Singh M. 2010. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 27:247–259.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Araujo J, Garcia ML, Rakovsky E, Souto EB. 2010. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B Biointerfaces. 75:538–542.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E, Nikolic S, Garcia ML, Egea MA, Souto EB, Calpena AC. 2011. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J Pharm Sci. 100:242–251.
   PubMed Web of Science ®Google Scholar
• Higuchi T. 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J. 2012. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 20:813–830.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Gidwani B, Vyas A. 2016. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol. 44:27–40.
   PubMed Web of Science ®Google Scholar
• Khan SA, Ahmad M, Murtaza G, Aamir MN, Rasool F, Raees MA. 2011. Influence of process parameters on nimesulide-loaded poly(D,L-Lactide-Co-Glycolide) microcapsules. Latin Am J Pharm. 30:119–125.
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. 1983. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35.
   Web of Science ®Google Scholar
• Lenz QF, Guterres SS, Pohlmann A, Alves MP. 2012. Semi-solid topical formulations containing nimesulide-loaded nanocapsules showed in-vivo anti-inflammatory activity in chronic arthritis and fibrovascular tissue models. Inflamm Res. 61:305–310.
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, Zhong Z, Zhang Z. 2007. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 340:153–162.
   PubMed Web of Science ®Google Scholar
• Luan J, Zheng F, Yang X, Yu A, Zhai G. 2015. Nanostructured lipid carriers for oral delivery of baicalin: In vitro and in vivo evaluation. Colloids and Surfaces A. 466:154–159.
   Web of Science ®Google Scholar
• Madheswaran T, Baskaran R, Yong CS, Yoo BK. 2014. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. AAPS PharmSciTech. 15:44–51.
   PubMed Web of Science ®Google Scholar
• Monica G, Jovita K, Sanjay T, Shubhini SA. 2014. Development of piroxicam loaded nanostructured lipid carriers for spondylitis treatment. Adv Sci Lett. 20:1066–1071.
   Google Scholar
• Muller RH, Shegokar R, Keck CM. 2011. 20 Years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol. 8:207–227.
   PubMedGoogle Scholar
• Narala A, Veerabrahma K. 2013. Preparation, characterization and evaluation of quetiapine fumarate solid lipid nanoparticles to improve the oral bioavailability. J Pharm. 2013:265741.
   Google Scholar
• Nasr M, Mansour S, Mortada ND, El Shamy AA. 2008. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 9:154–162.
   PubMed Web of Science ®Google Scholar
• Patel D, Dasgupta S, Dey S, Ramani YR, Ray S, Mazumder B. 2012. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci Pharm. 80:749–764.
   PubMedGoogle Scholar
• Patil GB, Patil ND, Deshmukh PK, Patil PO, Bari SB. 2016. Nanostructured lipid carriers as a potential vehicle for carvedilol delivery: application of factorial design approach. Artif Cells Nanomed Biotechnol. 44:12–19.
   PubMed Web of Science ®Google Scholar
• Peppas NA. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 60:110–111.
   PubMedGoogle Scholar
• Pradhan M, Singh D, Singh MR. 2016. Influence of selected variables on fabrication of triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders. Artif Cells Nanomed Biotechnol. 44:392–400.
   PubMed Web of Science ®Google Scholar
• Rahman Z, Zidan AS, Khan MA. 2010. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm. 76:127–137.
   PubMed Web of Science ®Google Scholar
• Raj R, Mongia P, Ram A, Jain NK. 2015. Enhanced skin delivery of aceclofenac via hydrogel-based solid lipid nanoparticles. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1036997.
   PubMed Web of Science ®Google Scholar
• Ramjith US, Mathew T. 2015. A review on some of the banned drugs which are still available in india. Int J Curr Res Chem Pharma Sci. 2:76–83.
   Google Scholar
• Schramlova J, Blazek K, Bartackova M, Otova B, Mardesicova L, Zizkovsky V, Hulinska D. 1997. Electron microscopic demonstration of the penetration of liposomes through skin. Folia Biol (Praha). 43:165–169.
   PubMed Web of Science ®Google Scholar
• Shahzad Y, Afreen U, Nisar Hussain Shah S, Hussain T. 2013. Applying response surface methodology to optimize nimesulide permeation from topical formulation. Pharm Dev Technol. 18:1391–1398.
   PubMed Web of Science ®Google Scholar
• Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare OP. 2005. Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv. 2:143–153.
   PubMedGoogle Scholar
• Thakkar HP, Desai JL, Parmar MP. 2014. Application of Box–Behnken design for optimization of formulation parameters for nanostructured lipid carriers of candesartan cilexetil. Asian J Pharm. 8:81–89.
   Google Scholar
• Thatipamula R, Palem C, Gannu R, Mudragada S, Yamsani M. 2011. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. Daru. 19:23–32.
   PubMed Web of Science ®Google Scholar
• Tichota DM, Silva AC, Sousa Lobo JM, Amaral MH. 2014. Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration. Int J Nanomedicine. 9:3855–3864.
   PubMed Web of Science ®Google Scholar
• Uner M, Karaman EF, Aydogmus Z. 2014. Solid lipid nanoparticles and nanostructured lipid carriers of loratadine for topical application: physicochemical stability and drug penetration through rat skin. Trop J Pharm Res. 13:653–660.
   Web of Science ®Google Scholar
• Uprit S, Kumar Sahu R, Roy A, Pare A. 2013. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J. 21:379–385.
   PubMed Web of Science ®Google Scholar
• Vandana KR, Yalavarthi PR, Sundaresan CR, Sriramaneni RN, Vadlamudi HC. 2014. In-vitro assessment and pharmacodynamics of nimesulide incorporated Aloe vera transemulgel. Curr Drug Discov Technol. 11:162–167.
   PubMedGoogle Scholar
• Woo JO, Misran M, Lee PF, Tan LP. 2014. Development of a controlled release of salicylic acid loaded stearic acid-oleic acid nanoparticles in cream for topical delivery. Scientific World J. 2014:205703
   Web of Science ®Google Scholar
• Zur Muhlen A, Mehnert W. 1998. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie. 53:552–555.
   Web of Science ®Google Scholar